Latest Regulatory News

Reach Resources reports exceptional metallurgical test results from its Murchison South Gold Project, highlighting high gold recoveries and favourable processing characteristics that support toll milling potential.

Celsius Resources Limited has had its trading suspension lifted following an announcement about its Supreme Court application challenging the validity of its prior auditor's 2011 resignation.

US Masters Residential Property Group aims to divest its entire portfolio by the end of 2026, signalling an end to its operations. The group will prepare 2025 financials on a non-going concern basis, reflecting this strategic wind-down.

Fortuna Metals has reported significant high-grade rutile mineralisation at its Mkanda project in Malawi, with assays from 96 drill holes revealing a mineralised footprint extending over 25km. The Malawi government has confirmed the company’s exemption from raw mineral export restrictions, supporting its in-country beneficiation plans.

Cannindah Resources has successfully raised over $11 million through the first tranche of its share placement, with the second tranche awaiting shareholder approval in March 2026.

Sky Metals has revealed significant new tin mineralisation extensions at its Tallebung project in NSW, confirmed by recent drilling and surface sampling. The company is advancing a major resource update, signalling strong growth potential.

Orion Minerals has locked in a US$250 million prepayment facility with Glencore to fund key developments at its Prieska Copper Zinc Project, marking a pivotal step toward production in South Africa.

Paradigm Biopharmaceuticals has entered a binding agreement with AVet Health to co-develop and license a novel oral therapy for veterinary osteoarthritis in Australia and New Zealand, unlocking new market potential while advancing its human clinical trials.

Algorae Pharmaceuticals has secured a key Licence & Supply Agreement with Cadila Pharmaceuticals to commercialise two generic cardiovascular and metabolic medicines in Australia and New Zealand, broadening its therapeutic reach beyond oncology.

DeSoto Resources has significantly expanded its footprint in Guinea’s prolific Siguiri Basin by acquiring three new reconnaissance projects and advancing multiple exploration programs across its portfolio.

Memphasys Limited has secured Therapeutic Goods Administration approval for its Felix™ System two months ahead of schedule, enabling immediate commercial sales and clinical use in Australia.

DGR Global has been flagged by ASX for breaching Listing Rule 10.1 after advancing $500,000 without prior shareholder approval. The company is now preparing to seek retroactive approval and address further funding tranches.